NCT01844973View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Psoriasis
Interventions
DRUG

M518101

Proper quantity twice a day

DRUG

Vehicle

Proper quantity twice a day

Trial Locations (1)

92780

Orenge County Research Center, Tustin

All Listed Sponsors
lead

Maruho North America Inc.

INDUSTRY

NCT01844973 - Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients | Biotech Hunter | Biotech Hunter